BioSpace · 3 days ago
QA Representative Batch Disposition
Wonder how qualified you are to the job?
BiotechnologyCommunities
Insider Connection @BioSpace
Responsibilities
Support the site in the development and execution of the site readiness plan with focus on supporting development of the site e-release process and startup of new systems
Performs final batch disposition of semi-finished and/or finished drug product and combination product batches, to ensure high-quality medicine (GMP Compliance) is released to market in a timely manner
Effectively review/approve GMP documents to ensure quality attributes are met (i.e.: Deviations, procedures, protocols, specifications, and change controls)
Qualification
Find out how your skills align with this job's requirements. If anything seems off, you can easily click on the tags to select or unselect skills to reflect your actual expertise.
Required
Bachelor’s degree in a science, engineering, computer, or pharmaceutical related field of study or equivalent experience
Experience working in the pharmaceutical or medical device industry in QA roles
Previous batch disposition experience
Preferred
Proficiency with SAP, MES, and Trackwise
Root cause analysis/troubleshooting skills
Previous regulatory inspection readiness and inspection execution experience
Previous experience with Event and Change Management process
Previous experience with device and parenteral product materials
Previous experience with applicable computer systems
Ability to work 8-hour days – Monday through Friday Day Shift (not eligible for remote work)
Ability to travel up to 10% for meetings and coordination with global or existing manufacturing sites
Qualified candidates must be legally authorized to be employed in the United States. Lilly does not anticipate providing sponsorship for employment visa status (e.g., H-1B or TN status) for employment positions on the B or S paths or at levels M1-M2 or R1-R4.
Company
BioSpace
BioSpace is the leading online community for industry news and careers for life science professionals.
Funding
Current Stage
Growth StageTotal Funding
$10M2000-08-24Series B· $10M
Recent News
2024-05-31
2024-05-05
2024-04-06
Company data provided by crunchbase